HRAS and neurodegenerative disease: Rho GTPases, including HRAS, have significant therapeutic potential in the treatment of neurodegenerative diseases, as they have been implicated in nearly all stages of brain development (Zamboni et al., 2018; Schmidt et al., 2022).